SCHEMBL695839

SCHEMBL695839

FC(F)(F)c1cnc(-c2cc3c[c]ccc3[nH]2)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PKM P14618 2/20 0.38
PLAU P00749 1/20 0.37
GAA P10253 1/20 0.36
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL695181 0.78 NPSR1 (0.37) KDM4EL3MBTL1
SCHEMBL694758 0.73 CCNB2 (0.43) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL16240902 0.72 NPC1 (0.55) ALDH1A1SMN1; SMN2KDM4EPOLBNPC1
SCHEMBL699731 0.70 PIK3CA (0.38)
SCHEMBL695489 0.69 SCN2A (0.47) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL694773 0.68 KDM4E (0.36) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL19460559 0.68 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2KDM4EPOLBNPC1
SCHEMBL17442639 0.68 BACE1 (0.34) ALDH1A1SMN1; SMN2KDM4EPOLBNPC1
SCHEMBL9045785 0.67 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2KDM4EPOLBNPC1
SCHEMBL694912 0.67 ITK (0.31) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed